Skip to main content

Table 2 Response of participants to the 4-item Medication Adherence Questions (MAQ) at baseline and 6-month post-baseline

From: Pharmacist-led intervention in treatment non-adherence and associated direct costs of management among ambulatory patients with type 2 diabetes in southwestern Nigeria

Items

Control (n = 95)

 

Mc Nemar test

Intervention (n = 106)

Mc Nemar test

Baseline

6-month post baseline

p-value

Baseline

6-month post baseline

p-value

Yes n(%)

No

n (%)

Yes

n (%)

No n(%)

 

Yes n(%)

No

n(%)

Yes n(%)

No

n(%)

 

1. Are there times when you forget to take your DM/HHDx medicine(s)?

8 (8.4)

88 (92.6)

5 (5.3)

90 (94.7)

0.219

15 (14.2)

91 (85.8)

8 (7.5)

98 (92.5)

0.017*

2. Do you have problems remembering to take your DM/HHDx medication(s) in past few weeks?

17 (17.9)

78 (82.1)

14 (14.7)

91 (95.8)

0.607

36(34.0)

70 (66.0)

12(11.3)

94 (88.7)

0.000*

3. Are there times when you feel much better and you discontinue your DM/HHDx medicine(s)?

4 (4.2)

91 (95.8)

1 (1.1)

94 (98.9)

0.25

5 (4.7)

101 (95.3)

2 (1.9)

104 (98.1)

1.00

4. Are there times when you feel uncomfortable with your medicine(s) and you stop taking them?

3 (3.2)

92 (96.8)

4 (4.2)

91 (95.8)

1.00

4 (3.8)

102 (96.2)

2 (1.9)

104 (98.1)

0.687

  1. HHDX: Hypertensive Heart Disease; Control group - HbA1c < 7.0%; Intervention group - HbA1c ≥ 7%. A ‘No’ response to all the 4-item questions was considered as total (100%) commitment to medication-taking/adherence, while a ‘Yes’ response to any of the 4-item questions indicated suboptimal (< 100%) adherence. *Significant difference with McNemar test, Level of significant p < 0.05